Expanding Indications: Beyond obesity, Zepbound is being explored for cardiovascular risk reduction, heart failure, and even Alzheimers disease management
Whether the magnitude, tempo, and reproductive consequences of rebound are the same in women with PCOS remains unknown
Medications with narrow therapeutic windows (like warfarin, levothyroxine, or certain diabetes medications) may need dose adjustments when combined with semaglutide
Epclusa represents the first all-oral, pan-genotypic, single tablet regimen for the treatment genotype 1-6 chronic hepatitis C virus (HCV) infection
Diabetes & Metabolism Journal 49 (3)
You can use whichever thumb is more comfortable